Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells.

about

Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy.

P2860

Q54977126-94BB729E-C2CC-4403-B028-B04C76A1389E

P2860

Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells.

Item

http://www.wikidata.org/entity/Q52370039

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Anti-mitotic chemotherapeutics ...... th receptor 3 in cancer cells.

@en

Anti-mitotic chemotherapeutics ...... th receptor 3 in cancer cells.

@nl

type

Item

label

Anti-mitotic chemotherapeutics ...... th receptor 3 in cancer cells.

@en

Anti-mitotic chemotherapeutics ...... th receptor 3 in cancer cells.

@nl

prefLabel

Anti-mitotic chemotherapeutics ...... th receptor 3 in cancer cells.

@en

Anti-mitotic chemotherapeutics ...... th receptor 3 in cancer cells.

@nl

P1476

Anti-mitotic chemotherapeutics ...... th receptor 3 in cancer cells.

@en

P2093

Chen Qi

http://www.w3.org/2001/XMLSchema#string

Gelin Wang

http://www.w3.org/2001/XMLSchema#string

Hong Yu

http://www.w3.org/2001/XMLSchema#string

Noelle Williams

http://www.w3.org/2001/XMLSchema#string

She Chen

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

Zhirong Shen

http://www.w3.org/2001/XMLSchema#string

P2860

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

Identification of a human mitotic checkpoint gene: hsMAD2

Identification of a ligand for the death-domain-containing receptor Apo3

Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95

LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing

Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis

Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis

Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination

Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)

P2888

s41422-018-0018-6

P304

544-555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41422-018-0018-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101290869

http://www.w3.org/2001/XMLSchema#string

P698

29497138

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

5951888

http://www.w3.org/2001/XMLSchema#string

Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells.

about

P2860

P2860

Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932